Stocks & ETFs Screener: 200+ results (Biotechnology)

Symbol	Industry	Market Cap	Fund. Score	Div. Score	Tech. Score	P/E	Return 12m vs S&P 500
ABBV AbbVie	Biotechnology Biologics, Immunology, Oncology	387B	50.4%	69.1%	90.8%	167	23.9%
AMGN Amgen	Biotechnology Rheumatoid Arthritis, Psoriasis	172B	82.4%	67.3%	49.1%	24.8	1.13%
GILD Gilead Sciences	Biotechnology Antivirals, Oncology, Hepatitis	147B	81.3%	61.0%	88.5%	18.3	22.2%
VRTX Vertex	Biotechnology Cystic Fibrosis, Sickle Cell, Beta	104B	85.8%	-	21.9%	28.8	-22.9%
REGN Regeneron	Biotechnology Eylea, Dupixent, Libtayo	69.1B	80.8%	13.4%	-21.9%	15.8	-23.8%
ALNY Alnylam	Biotechnology RNAi Therapeutics, Patisiran	59.8B	68.9%	-	87.6%	-	50.6%
ARGX argenx	Biotechnology Antibody,Autoimmune,Therapy,FcRn,Ig..	52.6B	74.5%	-	79.9%	36.5	30.6%
HLN Haleon	Biotechnology Toothpaste, Vitamins, Pain-Relief	41.3B	52.7%	53.2%	52.2%	21.1	-4.10%
INSM Insmed	Biotechnology Inhaled Antibiotic, DPP1	40.5B	33.8%	-	85.8%	-	137%
ONC BeiGene	Biotechnology BTK-Inhibitor, Anti-PD-1	36.9B	60.5%	-	64.9%	627	65.5%
NTRA Natera	Biotechnology Prenatal Screening, Carrier	27.5B	47.0%	-	65.6%	-	9.45%
BNTX BioNTech SE	Biotechnology Oncology Vaccines,Checkpoint	24.8B	15.7%	1.0%	-48.5%	-	-18.2%
22UA BioNTech SE	Biotechnology Cancer Vaccines, mRNA Therapies	24.6B	12.7%	1.0%	-58.5%	-	-24.9%
BIIB Biogen	Biotechnology Multiple Sclerosis Therapies	21.9B	72.2%	-	-43.1%	14.3	-12.8%
INCY Incyte	Biotechnology JAKAFI, MONJUVI, PEMAZYRE	20.8B	89.9%	-	33.6%	18.0	15.0%
UTHR United Therapeutics	Biotechnology Treprostinil, Treprostinil	19.2B	92.4%	-	55.7%	16.9	1.35%
GMAB Genmab AS	Biotechnology Antibody, Cancer, Lymphoma	17.7B	81.9%	-	-2.32%	12.6	22.6%
BIM Biomerieux	Biotechnology Diagnostic, Instruments, Reagents	15.3B	80.4%	61.1%	34.0%	33.6	-5.44%
NBIX Neurocrine	Biotechnology Movement, Endocrine	14.3B	88.2%	-	41.5%	34.1	0.84%
ROIV Roivant Sciences	Biotechnology Antibody, Small-Molecule, Inhaled	13.7B	30.2%	-	79.9%	-	51.1%
SMMT Summit Therapeutics	Biotechnology Antibody, Immunotherapy, Oncology	13.5B	45.6%	-	59.2%	-	-17.7%
EXAS EXACT Sciences	Biotechnology Colorectal, Breast, Colon	12.5B	46.4%	-	22.8%	-	17.3%
ERF Eurofins	Biotechnology Testing, Laboratory, Services	12.5B	67.8%	2.68%	19.7%	25.6	17.5%
ASND Ascendis Pharma AS	Biotechnology Growth Hormone	12.0B	32.9%	-	77.8%	-	43.8%
IONS Ionis	Biotechnology Triglyceride, Amyloidosis, SMA	11.9B	22.9%	0.21%	59.6%	-	62.3%
BBIO BridgeBio Pharma	Biotechnology ATTR Medication, FGFR Inhibitor	11.9B	50.6%	-	83.1%	-	130%
RVMD Revolution	Biotechnology RAS Inhibitors, Companion	11.8B	25.4%	-	54.1%	-	-2.77%
MRNA Moderna	Biotechnology Respiratory Vaccines, Latent	11.0B	25.0%	-	-85.7%	-	-48.0%
EXEL Exelixis	Biotechnology Cabozantinib, Cobimetinib	10.9B	94.0%	-	80.9%	17.2	5.66%
RNA Avidity Biosciences	Biotechnology Antibody-Oligonucleotide	10.3B	29.5%	-	74.9%	-	18.5%
BMRN Biomarin	Biotechnology Enzyme replacement therapy	9.89B	87.7%	-	-63.5%	19.1	-28.6%
MDGL Madrigal	Biotechnology Rezdiffra, Liver Therapy, MASH	9.53B	49.0%	-	80.9%	-	43.5%
ABVX Abivax American	Biotechnology Obefazimod, Immunoregulatory	8.60B	38.8%	-	73.8%	-	770%
ABVX Abivax	Biotechnology Drug, Phase3, Ulcerative, Crohns	8.49B	39.1%	-	66.0%	-	722%
HALO Halozyme	Biotechnology Enzyme, Cancer, Immunodeficiency	8.02B	92.2%	-	52.2%	14.4	6.64%
CYTK Cytokinetics	Biotechnology Cardiac Activator, Skeletal	7.36B	43.1%	-	38.3%	-	2.79%
MRUS Merus BV	Biotechnology Bispecific Antibodies, BIZENGRI	7.24B	31.2%	-	90.8%	-	65.6%
GRFS Grifols	Biotechnology Immunoglobulin, Albumin	7.21B	64.6%	41.7%	18.1%	13.4	-14.6%
NUVL Nuvalent	Biotechnology ROS1 Inhibitor, ALK Inhibitor	6.79B	25.4%	-	59.5%	-	-7.99%
RYTM Rhythm	Biotechnology Setmelanotide, Rare Obesity, MC4R	6.69B	43.2%	-	92.0%	-	40.2%
RGC Regencell	Biotechnology Traditional Chinese Medicine	6.44B	36.4%	-	79.2%	-	6,784%
LEGN Legend Biotech	Biotechnology CAR-T, Oncology, Myeloma	5.92B	32.2%	-	-44.0%	-	-30.8%
PTCT PTC Therapeutics	Biotechnology Translarna, Emflaza, Upstaza	5.76B	64.5%	-	59.1%	8.35	49.5%
KRYS Krystal Biotech	Biotechnology Gene, Therapy, Topical, Wound, Skin	5.73B	89.1%	-	60.3%	29.7	-4.11%
TGTX TG Therapeutics	Biotechnology Anti-CD20 Antibody, BTK Inhibitor	5.52B	66.7%	-	35.4%	91.5	-22.1%
PCVX Vaxcyte	Biotechnology Pneumococcal, Streptococcus	5.45B	26.9%	-	-15.0%	-	-58.6%
ARWR Arrowhead	Biotechnology Plozasiran, Olpasiran, Fazirsiran	5.42B	34.9%	-	20.5%	-	67.0%
ALKS Alkermes	Biotechnology Schizophrenia, Bipolar, Alcohol	5.02B	86.5%	-	30.7%	15.1	-6.89%
CRSP Crispr Therapeutics	Biotechnology Gene-Edited Cell Therapy, CAR T	5.01B	25.0%	-	1.49%	-	-9.88%
ACLX Arcellx	Biotechnology Anitocabtagene Autoleucel	5.01B	37.5%	-	54.5%	-	-23.4%
PTGX Protagonist	Biotechnology Peptide, Hematology, Inflammation	4.97B	62.2%	-	88.6%	121	71.3%
AKRO Akero Therapeutics	Biotechnology Efruxifermin, FGF21 Analog, MASH	4.47B	26.4%	-	44.1%	-	53.7%
KYMR Kymera Therapeutics	Biotechnology IRAK4, STAT6, TYK2, Protein	4.41B	27.2%	-	54.7%	-	14.9%
IMVT Immunovant	Biotechnology Monoclonal Antibodies, Autoimmune	4.33B	29.6%	-	12.3%	-	-30.7%
PRAX Praxis Precision	Biotechnology Cns Therapies, Epilepsy Treatments	4.21B	29.8%	-	45.7%	-	91.3%
QURE Uniqure	Biotechnology Gene Therapy, Hemophilia Treatment	4.18B	42.5%	-	31.1%	-	292%
NAMS NewAmsterdam	Biotechnology Obicetrapib, Ezetimibe, CETP	4.17B	34.8%	-	76.9%	-	30.0%
MTSR Metsera, Common	Biotechnology Injectable, Oral, Obesity, Peptides	4.12B	47.9%	-	91.0%	-	250%
VKTX Viking Therapeutics	Biotechnology VK2809, VK2735, VK5211, VK0214	4.07B	27.6%	-	39.2%	-	-37.8%
INDV Indivior Ordinary	Biotechnology Suboxone, Sublocade, Subutex, Opvee	4.00B	74.5%	2.63%	57.8%	32.7	158%
LGND Ligand	Biotechnology Infectious, Oncology, Nephrology	3.95B	45.3%	0.14%	80.6%	89.2	44.7%
BLTE Belite Bio	Biotechnology Oral Therapy, Stargardt	3.90B	37.2%	-	80.5%	-	20.0%
ACAD ACADIA	Biotechnology Parkinsons Psychosis Drug, Rett	3.82B	86.1%	-	49.9%	14.6	18.0%
CRNX Crinetics	Biotechnology Paltusotine, Atumelnant, CRN09682	3.80B	22.7%	-	32.4%	-	-38.3%
APGE Apogee	Biotechnology Monoclonal Antibody, Atopic	3.72B	48.6%	-	57.2%	-	4.72%
MIRM Mirum	Biotechnology LIVMARLI, Cholbam, Chenodal	3.50B	48.4%	-	91.4%	-	38.4%
ADMA ADMA Biologics	Biotechnology IVIG, Immune Globulin, Hepatitis	3.46B	84.8%	-	37.1%	16.9	-35.8%
VCYT Veracyte	Biotechnology Thyroid, Prostate, Bladder	3.35B	62.2%	-	5.35%	111	-11.5%
CDTX Cidara Therapeutics	Biotechnology Antifungal, Antiviral, Oncology	3.28B	22.2%	-	77.4%	-	569%
CGON CG Oncology	Biotechnology Oncolytic Immunotherapy	3.19B	36.1%	-	-2.33%	-	-5.69%
IRON Disc Medicine	Biotechnology Porphyria Drug, Anemia Drug	3.17B	28.8%	-	39.8%	-	21.2%
CELC Celcuity	Biotechnology Cancer Test, Therapy Candidate	3.16B	28.7%	-	75.9%	-	416%
CNTA Centessa	Biotechnology Sleep Disorder Drug	2.97B	35.3%	-	67.5%	-	26.1%
ARQT Arcutis	Biotechnology Topical Cream, Topical Foam, JAK1	2.97B	41.4%	-	32.2%	-	91.7%
XENE Xenon	Biotechnology Kv7 Opener, Phase 3, Epilepsy	2.96B	33.7%	-	18.8%	-	-16.2%
RARE Ultragenyx	Biotechnology Biologic, Gene Therapy, Antibody	2.96B	36.4%	-	-50.4%	-	-40.7%
MLYS Mineralys	Biotechnology Hypertension, Mineralocorticoid	2.95B	32.7%	-	74.2%	-	212%
KNSA Kiniksa	Biotechnology ARCALYST, Vixarelimab, KPL-387	2.91B	71.2%	-	91.8%	85.3	56.4%
TVTX Travere	Biotechnology Medication, Tablets, Enzyme	2.89B	30.3%	-	34.3%	-	60.3%
GRAL GRAIL	Biotechnology Diagnostic, Screening, Cancer	2.86B	40.2%	-	91.4%	-	359%
SRRK Scholar Rock	Biotechnology Monoclonal Antibodies, Inhibitor	2.85B	27.1%	-	31.5%	-	-3.58%
IDYA Ideaya Biosciences	Biotechnology Oncology, Kinase, Inhibitor, ADC	2.65B	25.2%	-	45.8%	-	-8.38%
CPRX Catalyst	Biotechnology Firdapse, Fycompa, Ruzurgi, Agamree	2.63B	91.1%	-	24.8%	12.5	-11.4%
DYN Dyne Therapeutics	Biotechnology Therapeutics, Muscular Dystrophy	2.62B	29.1%	-	10.6%	-	-51.6%
SLNO Soleno Therapeutics	Biotechnology Diazoxide, Choline, Tablet, Rare	2.56B	41.7%	-	63.8%	-	-25.3%
AGIO Agios Pharm	Biotechnology Mitapivat, Tebapivat, AG-181	2.51B	35.9%	-	19.1%	-	-36.3%
ZLAB Zai Lab	Biotechnology Oncology, Immunology	2.46B	30.1%	-	-34.9%	-	-36.3%
APLS Apellis	Biotechnology Therapeutic, Complement	2.44B	79.9%	-	-61.9%	53.5	-38.4%
RXRX Recursion	Biotechnology Drug Discovery Platform	2.41B	26.6%	-	-73.3%	-	-48.1%
DNLI Denali Therapeutics	Biotechnology RIPK1 Inhibitor, LRRK2 Inhibitor	2.38B	26.3%	-	-66.5%	-	-49.2%
FOLD Amicus Therapeutics	Biotechnology Galafold, Pombiliti, Opfolda, Gene	2.35B	48.1%	-	-34.5%	-	-20.6%
NNNN Anbio	Biotechnology Antigen Tests, Immunoassay	2.32B	66.8%	-	86.6%	858	265%
COGT Cogent Biosciences	Biotechnology Kinase Inhibitor, FGFR Inhibitor	2.28B	46.8%	-	62.3%	-	186%
BEAM Beam Therapeutics	Biotechnology Base-Editing Therapeutics, Sickle	2.25B	26.2%	-	-65.6%	-	-30.9%
VRDN Viridian	Biotechnology Monoclonal Antibody, Thyroid Eye	2.20B	42.8%	-	17.6%	-	11.3%
RCUS Arcus Biosciences	Biotechnology Cancer, Immuno-Oncology	2.13B	34.0%	-	-24.8%	-	5.75%
GPCR Structure	Biotechnology Small,Molecule,Drug,Candidates,Obes..	2.12B	32.4%	-	15.8%	-	-15.5%
GLPG Galapagos	Biotechnology CAR-T, Oncology, Immunology	2.10B	27.4%	-	-11.1%	-	-7.99%
IBRX Immunitybio	Biotechnology Immunotherapy, Vaccine, Cytokine	2.10B	66.8%	-	-75.8%	-	-63.7%
GLPG Galapagos	Biotechnology Medicine, Oncology, Immunology	2.08B	41.0%	-	-1.71%	-	0.31%
VCEL Vericel Ord	Biotechnology Cartilage, Skin, Burn, Autologous	1.97B	60.0%	-	1.0%	150	-36.9%
MESO Mesoblast	Biotechnology Stem-Cell Therapy, Inflammation	1.87B	31.7%	-	37.6%	-	11.9%
TWST Twist Bioscience	Biotechnology Synthetic DNA, Gene Fragments	1.87B	38.1%	-	-32.9%	-	-38.2%
SRPT Sarepta	Biotechnology RNA Therapeutics, Duchenne	1.85B	29.7%	-	-77.1%	-	-86.1%
EWTX Edgewise	Biotechnology Muscle Disorder Therapies	1.82B	29.6%	-	4.80%	-	-46.1%
ALVO Alvotech	Biotechnology Biosimilar, Autoimmune, Oncology	1.78B	52.6%	-	-38.7%	24.8	-59.4%
SYRE Spyre Therapeutics	Biotechnology Monoclonal, Antibodies	1.75B	30.6%	-	-40.7%	-	-39.8%
AUPH Aurinia	Biotechnology Immunosuppressant, Lupus	1.73B	88.7%	-	58.1%	30.6	61.4%
IMCR Immunocore Holdings	Biotechnology Oncology Immunotherapy	1.69B	43.2%	-	-14.5%	-	-9.12%
MNKD MannKind	Biotechnology Inhaled,Insulin,Diabetes,Respirator..	1.66B	64.1%	-	-6.64%	54.2	-36.1%
JANX Janux Therapeutics	Biotechnology JANX007, JANX008, TRACTr, TRACIr	1.66B	27.9%	-	-0.12%	-	-53.6%
NUVB Nuvation Bio	Biotechnology Oncology Pipeline Drug Candidates	1.62B	34.1%	-	46.5%	-	39.6%
ZBIO Zenas BioPharma	Biotechnology Bifunctional Monoclonal Antibody	1.58B	33.4%	-	80.1%	-	63.9%
ATAI ATAI Life Sciences	Biotechnology Psychedelic, Intranasal, Oral	1.58B	40.8%	-	44.7%	-	169%
VERA Vera Therapeutics	Biotechnology Atacicept, Mab, Dual-Inhibitor	1.55B	22.9%	3.50%	10.9%	-	-49.6%
CLDX Celldex	Biotechnology Monoclonal Antibody, Bispecific	1.52B	45.8%	-	-27.2%	-	-22.4%
BCRX BioCryst	Biotechnology Antiviral Injection, Oral HAE	1.49B	72.3%	-	-40.6%	-	-20.7%
MEDCL Medincell	Biotechnology Schizophrenia, Postoperative Pain	1.48B	54.7%	-	77.8%	-	50.6%
ARDX Ardelyx	Biotechnology IBS-C Therapy, Phosphate	1.47B	30.1%	-	51.9%	-	13.7%
IMNM Immunome	Biotechnology Antibody, Oncology, Bispecific	1.40B	47.3%	-	52.0%	-	25.1%
PGEN Precigen	Biotechnology UltraCAR-T, AdenoVerse, PRGN-3005	1.40B	31.7%	-	55.9%	-	270%
DNTH Dianthus	Biotechnology Monoclonal Antibody, DNTH103	1.39B	28.8%	-	26.4%	-	18.3%
PHVS Pharvaris BV	Biotechnology Bradykinin, Antagonist	1.39B	31.4%	-	69.0%	-	6.28%
ZYME Zymeworks Common	Biotechnology Bispecific Antibodies	1.36B	35.0%	-	50.0%	-	-5.63%
ORKA Oruka Therapeutics	Biotechnology Monoclonal Antibody	1.34B	28.3%	1.0%	34.3%	-	-9.71%
SNDX Syndax	Biotechnology Antibody, Kinase, Inhibitor	1.31B	40.0%	-	-18.8%	-	-12.1%
STOK Stoke Therapeutics	Biotechnology STK-002,Zorevunersen,ASOs,TANGO,Gen..	1.31B	86.1%	-	58.5%	33.6	64.7%
NRIX Nurix Therapeutics	Biotechnology BTK Degrader, IRAK4 Degrader	1.26B	30.8%	-	-42.9%	-	-59.8%
UPB Upstream Bio	Biotechnology Verekitug, Asthma, Rhinosinusitis	1.24B	38.0%	-	35.9%	-	-20.9%
NVAX Novavax	Biotechnology Vaccine, Adjuvant, Nanoparticle	1.21B	40.5%	-	-49.8%	3.70	-20.2%
ABCL Abcellera Biologics	Biotechnology Antibody, Discovery, Therapeutics	1.21B	19.3%	-	-23.4%	-	8.84%
DVAX Dynavax	Biotechnology Vaccine, Infectious Diseases	1.20B	40.7%	-	-38.7%	-	-27.5%
ORIC Oric	Biotechnology Androgen, Kinase, Precision	1.20B	33.8%	-	55.9%	-	4.21%
CVAC CureVac	Biotechnology mRNA Vaccines, mRNA Therapies	1.17B	85.0%	-	-2.87%	5.26	69.2%
MNMD Mind Medicine	Biotechnology MM120, MM402, Anxiety, ADHD, Autism	1.16B	29.9%	-	64.9%	-	21.6%
MBX MBX Biosciences	Biotechnology Hypoparathyroidism, Hypoglycemia	1.15B	32.5%	-	34.4%	3.33	1.35%
OCS Oculis Holding	Biotechnology Ophthalmology,Eye,Drugs,Therapy,Tre..	1.11B	23.9%	-	60.6%	-	15.1%
PHARM Pharming	Biotechnology RUCONEST, Joenja, OTL-105	1.11B	62.4%	-	46.9%	-	82.5%
NTLA Intellia	Biotechnology CRISPR, Gene, Editing	1.10B	35.1%	-	-64.1%	-	-52.8%
IMTX Immatics	Biotechnology TCR-Engineered Cell Therapy, TCR	1.10B	27.1%	-	5.32%	-	2.24%
MDXG MiMedx	Biotechnology Allograft, Wound, Graft, Membrane	1.10B	79.4%	-	22.1%	27.4	-12.2%
SANA Sana Biotechnology	Biotechnology Allogeneic Islet Therapy, CAR-T	1.09B	34.6%	-	3.12%	-	20.8%
TNGX Tango Therapeutics	Biotechnology PRMT5 Inhibitor, Glioblastoma	1.06B	33.8%	-	22.3%	-	90.4%
TSHA Taysha Gene	Biotechnology Gene, Therapy, AAV, CNS, Monogenic	1.05B	37.0%	-	49.3%	-	59.3%
RLAY Relay Therapeutics	Biotechnology PI3Ka Inhibitor, Estrogen	1.05B	35.2%	-	-43.8%	-	-2.54%
OPK Opko Health	Biotechnology Diagnostics, Pharmaceuticals	1.03B	20.6%	-	-47.6%	-	-29.8%
NANO Nanobiotix S.A	Biotechnology Nanoparticle, Radiotherapy	1.00B	41.7%	-	72.3%	-	317%
DAWN Day One	Biotechnology Tovorafenib, DAY301, VRK1 Inhibitor	999M	31.3%	-	-73.5%	-	-47.7%
RZLT Rezolute	Biotechnology Antibody, Hyperinsulinism	998M	36.3%	-	68.6%	-	54.7%
XNCR Xencor	Biotechnology Engineered Monoclonal Antibodies	993M	19.3%	-	-73.3%	-	-48.0%
NBTX Nanobiotix	Biotechnology Nanoparticles, Radiotherapy	968M	46.0%	-	74.1%	-	355%
CSTL Castle Biosciences	Biotechnology Melanoma, Squamous, Uveal	964M	53.8%	-	11.7%	-	-5.80%
URGN UroGen Pharma	Biotechnology Jelmyto, UGN-102, UGN-103	947M	34.6%	-	65.5%	-	72.7%
ANAB AnaptysBio	Biotechnology Antibody, Autoimmune	941M	24.6%	-	34.7%	-	40.7%
KOD Kodiak Sciences	Biotechnology Anti-VEGF, Biopolymer Conjugate	931M	35.8%	-	42.4%	-	201%
IOVA Iovance	Biotechnology Amtagvi, Proleukin, Lifileucel	913M	42.7%	-	-82.9%	-	-76.5%
KURA Kura Oncology	Biotechnology Menin Inhibitor, Farnesyl	891M	49.6%	-	-36.6%	-	-47.2%
SPRY ARS	Biotechnology Epinephrine, Nasal Spray	875M	28.5%	-	8.02%	-	-47.6%
BHVN Biohaven	Biotechnology Troriluzole, Taldefgrobep	874M	41.2%	-	-62.7%	-	-85.5%
ABUS Arbutus Biopharma	Biotechnology RNAi Therapeutic, PD-L1 Inhibitor	863M	31.2%	-	48.8%	-	9.68%
PVLA Palvella	Biotechnology Topical Rapamycin Gel, Microcystic	861M	25.7%	-	27.1%	-	339%
PROK ProKidney	Biotechnology Cell Therapy, Renal Cells	853M	53.4%	-	-30.0%	-	-3.30%
TYRA Tyra Biosciences	Biotechnology Precision Medicine Platform, FGFR	844M	32.1%	-	27.1%	-	-13.0%
GHRS GH Research	Biotechnology Mebufotenin, Depression	837M	27.1%	-	40.1%	-	30.4%
VIR Vir Biotechnology	Biotechnology HDV, RSV, HPV, Coronavirus, TCE	828M	33.0%	-	-83.5%	-	-46.5%
VLA Valneva SE	Biotechnology Japanese Encephalitis, Cholera	805M	18.1%	-	-6.42%	-	45.3%
GLUE Monte Rosa	Biotechnology MRT-2359, MRT-6160, MRT-8102, CDK2	802M	86.3%	-	20.3%	38.5	45.7%
RAPT RAPT Therapeutics	Biotechnology CCR4 Antagonist, Inflammation	800M	29.4%	-	-28.3%	-	99.9%
BCAX Bicara	Biotechnology Ficerafusp Alfa, Bifunctional	800M	27.9%	-	-56.1%	-	-43.1%
CDNA CareDx	Biotechnology Kidney, Heart, Transplant	798M	50.1%	-	-38.0%	14.3	-38.8%
SVRA Savara	Biotechnology Molgramostim, Proteinosis	795M	26.5%	-	68.1%	-	15.1%
DNA Ginkgo Bioworks	Biotechnology Cell Engineering, Biosecurity	769M	18.4%	-	-46.6%	-	-18.3%
SION Sionna	Biotechnology Galicaftor, Navocaftor, SION-109	769M	34.4%	-	90.0%	-	78.3%
CMPX Compass	Biotechnology Tovecimig, CTX-471, CTX-8371	752M	24.6%	-	29.8%	-	148%
AVBP ArriVent	Biotechnology Firmonertinib, ARR-217, ARR-002	746M	42.6%	-	-23.1%	-	-45.8%
RIGL Rigel	Biotechnology Kinase, Inhibitor	725M	92.6%	-	64.4%	6.45	27.7%
LXEO Lexeo	Biotechnology Gene Therapy, Cardiomyopathy	720M	34.7%	-	-20.5%	-	3.31%
LENZ LENZ Therapeutics	Biotechnology Presbyopia, Accommodative	719M	38.5%	1.0%	8.82%	-	-36.0%
ORGO Organogenesis	Biotechnology Wound Care, Surgical Matrix	715M	33.6%	-	48.1%	-	23.1%
ATXS Astria Therapeutics	Biotechnology Monoclonal, Antibody, Plasma	706M	32.0%	-	22.2%	-	2.94%
REPL Replimune	Biotechnology Oncolytic Immunotherapy, RP1, RP2	683M	28.0%	-	-74.3%	-	-32.6%
GERN Geron	Biotechnology telomerase, inhibitor, oncology	683M	28.8%	-	-65.1%	-	-73.9%
MGTX MeiraGTx Holdings	Biotechnology Gene Therapies, Retinal Diseases	681M	27.2%	-	33.2%	-	3.01%
PRME Prime Medicine	Biotechnology Gene Editing, Prime Editing	679M	40.5%	-	-43.7%	-	-26.2%
EBS Emergent	Biotechnology Vaccine, Antitoxin, Auto-Injector	655M	52.4%	0.14%	-18.6%	9.45	-9.12%
ERAS Erasca	Biotechnology Naporafenib, ERAS-0015, ERAS-4001	644M	34.7%	-	-50.5%	-	-21.8%
MLTX MoonLake	Biotechnology Nanobody, IL-17A, IL-17F	641M	29.0%	-	13.6%	-	-78.4%
ESPR Esperion	Biotechnology Cholesterol-Lowering Tablets	631M	52.3%	-	-34.1%	-	16.5%
AVXL Anavex Life	Biotechnology Cns,Alzheimer,Parkinson,Rett,Epilep..	626M	30.1%	-	-51.3%	-	-43.8%
IVA Inventiva	Biotechnology Lanifibranor, Odiparcil, TGF-Beta	622M	46.0%	-	13.0%	-	26.1%
BCYC Bicycle	Biotechnology Bicycle, Conjugate, Nectin-4	607M	38.9%	-	-85.1%	-	-75.1%
CTMX CytomX Therapeutics	Biotechnology Antibody-Drug Conjugate, T-Cell	597M	60.6%	-	50.9%	7.24	236%
MYGN Myriad Genetics	Biotechnology Hereditary Cancer, Companion	587M	34.6%	0.08%	-78.9%	-	-64.7%
VSTM Verastem	Biotechnology Avutometinib, Defactinib	582M	40.8%	-	44.5%	-	73.7%
FDMT 4D Molecular	Biotechnology Ophthalmology, Cystic-Fibrosis	578M	28.5%	-	-24.3%	-	17.1%
OLMA Olema	Biotechnology Palazestrant, OP-3136, KAT6	573M	33.4%	-	21.5%	-	-39.3%
PRTA Prothena	Biotechnology Neurodegeneration, Antibody	568M	26.6%	-	-75.5%	-	-48.1%
CRVS Corvus	Biotechnology Kinase Inhibitor, Adenosine	568M	32.0%	-	46.4%	-	-20.8%
RGNX Regenxbio	Biotechnology Gene,Therapy,AAV,Platform,Pipeline	567M	23.4%	-	-25.8%	-	-4.23%
IVA Inventiva S.A	Biotechnology Lanifibranor, Odiparcil, TGF-Beta	565M	43.3%	-	9.20%	-	16.5%

ABBV
AbbVie

Biotechnology
Biologics, Immunology, Oncology

387B

50.4%

69.1%

90.8%

167

23.9%

AMGN
Amgen

Biotechnology
Rheumatoid Arthritis, Psoriasis

172B

82.4%

67.3%

49.1%

24.8

1.13%

GILD
Gilead Sciences

Biotechnology
Antivirals, Oncology, Hepatitis

147B

81.3%

61.0%

88.5%

18.3

22.2%

VRTX
Vertex

Biotechnology
Cystic Fibrosis, Sickle Cell, Beta

104B

85.8%

-

21.9%

28.8

-22.9%

REGN
Regeneron

Biotechnology
Eylea, Dupixent, Libtayo

69.1B

80.8%

13.4%

-21.9%

15.8

-23.8%

ALNY
Alnylam

Biotechnology
RNAi Therapeutics, Patisiran

59.8B

68.9%

-

87.6%

-

50.6%

ARGX
argenx

Biotechnology
Antibody,Autoimmune,Therapy,FcRn,Ig..

52.6B

74.5%

-

79.9%

36.5

30.6%

HLN
Haleon

Biotechnology
Toothpaste, Vitamins, Pain-Relief

41.3B

52.7%

53.2%

52.2%

21.1

-4.10%

INSM
Insmed

Biotechnology
Inhaled Antibiotic, DPP1

40.5B

33.8%

-

85.8%

-

137%

ONC
BeiGene

Biotechnology
BTK-Inhibitor, Anti-PD-1

36.9B

60.5%

-

64.9%

627

65.5%

NTRA
Natera

Biotechnology
Prenatal Screening, Carrier

27.5B

47.0%

-

65.6%

-

9.45%

BNTX
BioNTech SE

Biotechnology
Oncology Vaccines,Checkpoint

24.8B

15.7%

1.0%

-48.5%

-

-18.2%

22UA
BioNTech SE

Biotechnology
Cancer Vaccines, mRNA Therapies

24.6B

12.7%

1.0%

-58.5%

-

-24.9%

BIIB
Biogen

Biotechnology
Multiple Sclerosis Therapies

21.9B

72.2%

-

-43.1%

14.3

-12.8%

INCY
Incyte

Biotechnology
JAKAFI, MONJUVI, PEMAZYRE

20.8B

89.9%

-

33.6%

18.0

15.0%

UTHR
United Therapeutics

Biotechnology
Treprostinil, Treprostinil

19.2B

92.4%

-

55.7%

16.9

1.35%

GMAB
Genmab AS

Biotechnology
Antibody, Cancer, Lymphoma

17.7B

81.9%

-

-2.32%

12.6

22.6%

BIM
Biomerieux

Biotechnology
Diagnostic, Instruments, Reagents

15.3B

80.4%

61.1%

34.0%

33.6

-5.44%

NBIX
Neurocrine

Biotechnology
Movement, Endocrine

14.3B

88.2%

-

41.5%

34.1

0.84%

ROIV
Roivant Sciences

Biotechnology
Antibody, Small-Molecule, Inhaled

13.7B

30.2%

-

79.9%

-

51.1%

SMMT
Summit Therapeutics

Biotechnology
Antibody, Immunotherapy, Oncology

13.5B

45.6%

-

59.2%

-

-17.7%

EXAS
EXACT Sciences

Biotechnology
Colorectal, Breast, Colon

12.5B

46.4%

-

22.8%

-

17.3%

ERF
Eurofins

Biotechnology
Testing, Laboratory, Services

12.5B

67.8%

2.68%

19.7%

25.6

17.5%

ASND
Ascendis Pharma AS

Biotechnology
Growth Hormone

12.0B

32.9%

-

77.8%

-

43.8%

IONS
Ionis

Biotechnology
Triglyceride, Amyloidosis, SMA

11.9B

22.9%

0.21%

59.6%

-

62.3%

BBIO
BridgeBio Pharma

Biotechnology
ATTR Medication, FGFR Inhibitor

11.9B

50.6%

-

83.1%

-

130%

RVMD
Revolution

Biotechnology
RAS Inhibitors, Companion

11.8B

25.4%

-

54.1%

-

-2.77%

MRNA
Moderna

Biotechnology
Respiratory Vaccines, Latent

11.0B

25.0%

-

-85.7%

-

-48.0%

EXEL
Exelixis

Biotechnology
Cabozantinib, Cobimetinib

10.9B

94.0%

-

80.9%

17.2

5.66%

RNA
Avidity Biosciences

Biotechnology
Antibody-Oligonucleotide

10.3B

29.5%

-

74.9%

-

18.5%

BMRN
Biomarin

Biotechnology
Enzyme replacement therapy

9.89B

87.7%

-

-63.5%

19.1

-28.6%

MDGL
Madrigal

Biotechnology
Rezdiffra, Liver Therapy, MASH

9.53B

49.0%

-

80.9%

-

43.5%

ABVX
Abivax American

Biotechnology
Obefazimod, Immunoregulatory

8.60B

38.8%

-

73.8%

-

770%

ABVX
Abivax

Biotechnology
Drug, Phase3, Ulcerative, Crohns

8.49B

39.1%

-

66.0%

-

722%

HALO
Halozyme

Biotechnology
Enzyme, Cancer, Immunodeficiency

8.02B

92.2%

-

52.2%

14.4

6.64%

CYTK
Cytokinetics

Biotechnology
Cardiac Activator, Skeletal

7.36B

43.1%

-

38.3%

-

2.79%

MRUS
Merus BV

Biotechnology
Bispecific Antibodies, BIZENGRI

7.24B

31.2%

-

90.8%

-

65.6%

GRFS
Grifols

Biotechnology
Immunoglobulin, Albumin

7.21B

64.6%

41.7%

18.1%

13.4

-14.6%

NUVL
Nuvalent

Biotechnology
ROS1 Inhibitor, ALK Inhibitor

6.79B

25.4%

-

59.5%

-

-7.99%

RYTM
Rhythm

Biotechnology
Setmelanotide, Rare Obesity, MC4R

6.69B

43.2%

-

92.0%

-

40.2%

RGC
Regencell

Biotechnology
Traditional Chinese Medicine

6.44B

36.4%

-

79.2%

-

6,784%

LEGN
Legend Biotech

Biotechnology
CAR-T, Oncology, Myeloma

5.92B

32.2%

-

-44.0%

-

-30.8%

PTCT
PTC Therapeutics

Biotechnology
Translarna, Emflaza, Upstaza

5.76B

64.5%

-

59.1%

8.35

49.5%

KRYS
Krystal Biotech

Biotechnology
Gene, Therapy, Topical, Wound, Skin

5.73B

89.1%

-

60.3%

29.7

-4.11%

TGTX
TG Therapeutics

Biotechnology
Anti-CD20 Antibody, BTK Inhibitor

5.52B

66.7%

-

35.4%

91.5

-22.1%

PCVX
Vaxcyte

Biotechnology
Pneumococcal, Streptococcus

5.45B

26.9%

-

-15.0%

-

-58.6%

ARWR
Arrowhead

Biotechnology
Plozasiran, Olpasiran, Fazirsiran

5.42B

34.9%

-

20.5%

-

67.0%

ALKS
Alkermes

Biotechnology
Schizophrenia, Bipolar, Alcohol

5.02B

86.5%

-

30.7%

15.1

-6.89%

CRSP
Crispr Therapeutics

Biotechnology
Gene-Edited Cell Therapy, CAR T

5.01B

25.0%

-

1.49%

-

-9.88%

ACLX
Arcellx

Biotechnology
Anitocabtagene Autoleucel

5.01B

37.5%

-

54.5%

-

-23.4%

PTGX
Protagonist

Biotechnology
Peptide, Hematology, Inflammation

4.97B

62.2%

-

88.6%

121

71.3%

AKRO
Akero Therapeutics

Biotechnology
Efruxifermin, FGF21 Analog, MASH

4.47B

26.4%

-

44.1%

-

53.7%

KYMR
Kymera Therapeutics

Biotechnology
IRAK4, STAT6, TYK2, Protein

4.41B

27.2%

-

54.7%

-

14.9%

IMVT
Immunovant

Biotechnology
Monoclonal Antibodies, Autoimmune

4.33B

29.6%

-

12.3%

-

-30.7%

PRAX
Praxis Precision

Biotechnology
Cns Therapies, Epilepsy Treatments

4.21B

29.8%

-

45.7%

-

91.3%

QURE
Uniqure

Biotechnology
Gene Therapy, Hemophilia Treatment

4.18B

42.5%

-

31.1%

-

292%

NAMS
NewAmsterdam

Biotechnology
Obicetrapib, Ezetimibe, CETP

4.17B

34.8%

-

76.9%

-

30.0%

MTSR
Metsera, Common

Biotechnology
Injectable, Oral, Obesity, Peptides

4.12B

47.9%

-

91.0%

-

250%

VKTX
Viking Therapeutics

Biotechnology
VK2809, VK2735, VK5211, VK0214

4.07B

27.6%

-

39.2%

-

-37.8%

INDV
Indivior Ordinary

Biotechnology
Suboxone, Sublocade, Subutex, Opvee

4.00B

74.5%

2.63%

57.8%

32.7

158%

LGND
Ligand

Biotechnology
Infectious, Oncology, Nephrology

3.95B

45.3%

0.14%

80.6%

89.2

44.7%

BLTE
Belite Bio

Biotechnology
Oral Therapy, Stargardt

3.90B

37.2%

-

80.5%

-

20.0%

ACAD
ACADIA

Biotechnology
Parkinsons Psychosis Drug, Rett

3.82B

86.1%

-

49.9%

14.6

18.0%

CRNX
Crinetics

Biotechnology
Paltusotine, Atumelnant, CRN09682

3.80B

22.7%

-

32.4%

-

-38.3%

APGE
Apogee

Biotechnology
Monoclonal Antibody, Atopic

3.72B

48.6%

-

57.2%

-

4.72%

MIRM
Mirum

Biotechnology
LIVMARLI, Cholbam, Chenodal

3.50B

48.4%

-

91.4%

-

38.4%

ADMA
ADMA Biologics

Biotechnology
IVIG, Immune Globulin, Hepatitis

3.46B

84.8%

-

37.1%

16.9

-35.8%

VCYT
Veracyte

Biotechnology
Thyroid, Prostate, Bladder

3.35B

62.2%

-

5.35%

111

-11.5%

CDTX
Cidara Therapeutics

Biotechnology
Antifungal, Antiviral, Oncology

3.28B

22.2%

-

77.4%

-

569%

CGON
CG Oncology

Biotechnology
Oncolytic Immunotherapy

3.19B

36.1%

-

-2.33%

-

-5.69%

IRON
Disc Medicine

Biotechnology
Porphyria Drug, Anemia Drug

3.17B

28.8%

-

39.8%

-

21.2%

CELC
Celcuity

Biotechnology
Cancer Test, Therapy Candidate

3.16B

28.7%

-

75.9%

-

416%

CNTA
Centessa

Biotechnology
Sleep Disorder Drug

2.97B

35.3%

-

67.5%

-

26.1%

ARQT
Arcutis

Biotechnology
Topical Cream, Topical Foam, JAK1

2.97B

41.4%

-

32.2%

-

91.7%

XENE
Xenon

Biotechnology
Kv7 Opener, Phase 3, Epilepsy

2.96B

33.7%

-

18.8%

-

-16.2%

RARE
Ultragenyx

Biotechnology
Biologic, Gene Therapy, Antibody

2.96B

36.4%

-

-50.4%

-

-40.7%

MLYS
Mineralys

Biotechnology
Hypertension, Mineralocorticoid

2.95B

32.7%

-

74.2%

-

212%

KNSA
Kiniksa

Biotechnology
ARCALYST, Vixarelimab, KPL-387

2.91B

71.2%

-

91.8%

85.3

56.4%

TVTX
Travere

Biotechnology
Medication, Tablets, Enzyme

2.89B

30.3%

-

34.3%

-

60.3%

GRAL
GRAIL

Biotechnology
Diagnostic, Screening, Cancer

2.86B

40.2%

-

91.4%

-

359%

SRRK
Scholar Rock

Biotechnology
Monoclonal Antibodies, Inhibitor

2.85B

27.1%

-

31.5%

-

-3.58%

IDYA
Ideaya Biosciences

Biotechnology
Oncology, Kinase, Inhibitor, ADC

2.65B

25.2%

-

45.8%

-

-8.38%

CPRX
Catalyst

Biotechnology
Firdapse, Fycompa, Ruzurgi, Agamree

2.63B

91.1%

-

24.8%

12.5

-11.4%

DYN
Dyne Therapeutics

Biotechnology
Therapeutics, Muscular Dystrophy

2.62B

29.1%

-

10.6%

-

-51.6%

SLNO
Soleno Therapeutics

Biotechnology
Diazoxide, Choline, Tablet, Rare

2.56B

41.7%

-

63.8%

-

-25.3%

AGIO
Agios Pharm

Biotechnology
Mitapivat, Tebapivat, AG-181

2.51B

35.9%

-

19.1%

-

-36.3%

ZLAB
Zai Lab

Biotechnology
Oncology, Immunology

2.46B

30.1%

-

-34.9%

-

-36.3%

APLS
Apellis

Biotechnology
Therapeutic, Complement

2.44B

79.9%

-

-61.9%

53.5

-38.4%

RXRX
Recursion

Biotechnology
Drug Discovery Platform

2.41B

26.6%

-

-73.3%

-

-48.1%

DNLI
Denali Therapeutics

Biotechnology
RIPK1 Inhibitor, LRRK2 Inhibitor

2.38B

26.3%

-

-66.5%

-

-49.2%

FOLD
Amicus Therapeutics

Biotechnology
Galafold, Pombiliti, Opfolda, Gene

2.35B

48.1%

-

-34.5%

-

-20.6%

NNNN
Anbio

Biotechnology
Antigen Tests, Immunoassay

2.32B

66.8%

-

86.6%

858

265%

COGT
Cogent Biosciences

Biotechnology
Kinase Inhibitor, FGFR Inhibitor

2.28B

46.8%

-

62.3%

-

186%

BEAM
Beam Therapeutics

Biotechnology
Base-Editing Therapeutics, Sickle

2.25B

26.2%

-

-65.6%

-

-30.9%

VRDN
Viridian

Biotechnology
Monoclonal Antibody, Thyroid Eye

2.20B

42.8%

-

17.6%

-

11.3%

RCUS
Arcus Biosciences

Biotechnology
Cancer, Immuno-Oncology

2.13B

34.0%

-

-24.8%

-

5.75%

GPCR
Structure

Biotechnology
Small,Molecule,Drug,Candidates,Obes..

2.12B

32.4%

-

15.8%

-

-15.5%

GLPG
Galapagos

Biotechnology
CAR-T, Oncology, Immunology

2.10B

27.4%

-

-11.1%

-

-7.99%

IBRX
Immunitybio

Biotechnology
Immunotherapy, Vaccine, Cytokine

2.10B

66.8%

-

-75.8%

-

-63.7%

GLPG
Galapagos

Biotechnology
Medicine, Oncology, Immunology

2.08B

41.0%

-

-1.71%

-

0.31%

VCEL
Vericel Ord

Biotechnology
Cartilage, Skin, Burn, Autologous

1.97B

60.0%

-

1.0%

150

-36.9%

MESO
Mesoblast

Biotechnology
Stem-Cell Therapy, Inflammation

1.87B

31.7%

-

37.6%

-

11.9%

TWST
Twist Bioscience

Biotechnology
Synthetic DNA, Gene Fragments

1.87B

38.1%

-

-32.9%

-

-38.2%

SRPT
Sarepta

Biotechnology
RNA Therapeutics, Duchenne

1.85B

29.7%

-

-77.1%

-

-86.1%

EWTX
Edgewise

Biotechnology
Muscle Disorder Therapies

1.82B

29.6%

-

4.80%

-

-46.1%

ALVO
Alvotech

Biotechnology
Biosimilar, Autoimmune, Oncology

1.78B

52.6%

-

-38.7%

24.8

-59.4%

SYRE
Spyre Therapeutics

Biotechnology
Monoclonal, Antibodies

1.75B

30.6%

-

-40.7%

-

-39.8%

AUPH
Aurinia

Biotechnology
Immunosuppressant, Lupus

1.73B

88.7%

-

58.1%

30.6

61.4%

IMCR
Immunocore Holdings

Biotechnology
Oncology Immunotherapy

1.69B

43.2%

-

-14.5%

-

-9.12%

MNKD
MannKind

Biotechnology
Inhaled,Insulin,Diabetes,Respirator..

1.66B

64.1%

-

-6.64%

54.2

-36.1%

JANX
Janux Therapeutics

Biotechnology
JANX007, JANX008, TRACTr, TRACIr

1.66B

27.9%

-

-0.12%

-

-53.6%

NUVB
Nuvation Bio

Biotechnology
Oncology Pipeline Drug Candidates

1.62B

34.1%

-

46.5%

-

39.6%

ZBIO
Zenas BioPharma

Biotechnology
Bifunctional Monoclonal Antibody

1.58B

33.4%

-

80.1%

-

63.9%

ATAI
ATAI Life Sciences

Biotechnology
Psychedelic, Intranasal, Oral

1.58B

40.8%

-

44.7%

-

169%

VERA
Vera Therapeutics

Biotechnology
Atacicept, Mab, Dual-Inhibitor

1.55B

22.9%

3.50%

10.9%

-

-49.6%

CLDX
Celldex

Biotechnology
Monoclonal Antibody, Bispecific

1.52B

45.8%

-

-27.2%

-

-22.4%

BCRX
BioCryst

Biotechnology
Antiviral Injection, Oral HAE

1.49B

72.3%

-

-40.6%

-

-20.7%

MEDCL
Medincell

Biotechnology
Schizophrenia, Postoperative Pain

1.48B

54.7%

-

77.8%

-

50.6%

ARDX
Ardelyx

Biotechnology
IBS-C Therapy, Phosphate

1.47B

30.1%

-

51.9%

-

13.7%

IMNM
Immunome

Biotechnology
Antibody, Oncology, Bispecific

1.40B

47.3%

-

52.0%

-

25.1%

PGEN
Precigen

Biotechnology
UltraCAR-T, AdenoVerse, PRGN-3005

1.40B

31.7%

-

55.9%

-

270%

DNTH
Dianthus

Biotechnology
Monoclonal Antibody, DNTH103

1.39B

28.8%

-

26.4%

-

18.3%

PHVS
Pharvaris BV

Biotechnology
Bradykinin, Antagonist

1.39B

31.4%

-

69.0%

-

6.28%

ZYME
Zymeworks Common

Biotechnology
Bispecific Antibodies

1.36B

35.0%

-

50.0%

-

-5.63%

ORKA
Oruka Therapeutics

Biotechnology
Monoclonal Antibody

1.34B

28.3%

1.0%

34.3%

-

-9.71%

SNDX
Syndax

Biotechnology
Antibody, Kinase, Inhibitor

1.31B

40.0%

-

-18.8%

-

-12.1%

STOK
Stoke Therapeutics

Biotechnology
STK-002,Zorevunersen,ASOs,TANGO,Gen..

1.31B

86.1%

-

58.5%

33.6

64.7%

NRIX
Nurix Therapeutics

Biotechnology
BTK Degrader, IRAK4 Degrader

1.26B

30.8%

-

-42.9%

-

-59.8%

UPB
Upstream Bio

Biotechnology
Verekitug, Asthma, Rhinosinusitis

1.24B

38.0%

-

35.9%

-

-20.9%

NVAX
Novavax

Biotechnology
Vaccine, Adjuvant, Nanoparticle

1.21B

40.5%

-

-49.8%

3.70

-20.2%

ABCL
Abcellera Biologics

Biotechnology
Antibody, Discovery, Therapeutics

1.21B

19.3%

-

-23.4%

-

8.84%

DVAX
Dynavax

Biotechnology
Vaccine, Infectious Diseases

1.20B

40.7%

-

-38.7%

-

-27.5%

ORIC
Oric

Biotechnology
Androgen, Kinase, Precision

1.20B

33.8%

-

55.9%

-

4.21%

CVAC
CureVac

Biotechnology
mRNA Vaccines, mRNA Therapies

1.17B

85.0%

-

-2.87%

5.26

69.2%

MNMD
Mind Medicine

Biotechnology
MM120, MM402, Anxiety, ADHD, Autism

1.16B

29.9%

-

64.9%

-

21.6%

MBX
MBX Biosciences

Biotechnology
Hypoparathyroidism, Hypoglycemia

1.15B

32.5%

-

34.4%

3.33

1.35%

OCS
Oculis Holding

Biotechnology
Ophthalmology,Eye,Drugs,Therapy,Tre..

1.11B

23.9%

-

60.6%

-

15.1%

PHARM
Pharming

Biotechnology
RUCONEST, Joenja, OTL-105

1.11B

62.4%

-

46.9%

-

82.5%

NTLA
Intellia

Biotechnology
CRISPR, Gene, Editing

1.10B

35.1%

-

-64.1%

-

-52.8%

IMTX
Immatics

Biotechnology
TCR-Engineered Cell Therapy, TCR

1.10B

27.1%

-

5.32%

-

2.24%

MDXG
MiMedx

Biotechnology
Allograft, Wound, Graft, Membrane

1.10B

79.4%

-

22.1%

27.4

-12.2%

SANA
Sana Biotechnology

Biotechnology
Allogeneic Islet Therapy, CAR-T

1.09B

34.6%

-

3.12%

-

20.8%

TNGX
Tango Therapeutics

Biotechnology
PRMT5 Inhibitor, Glioblastoma

1.06B

33.8%

-

22.3%

-

90.4%

TSHA
Taysha Gene

Biotechnology
Gene, Therapy, AAV, CNS, Monogenic

1.05B

37.0%

-

49.3%

-

59.3%

RLAY
Relay Therapeutics

Biotechnology
PI3Ka Inhibitor, Estrogen

1.05B

35.2%

-

-43.8%

-

-2.54%

OPK
Opko Health

Biotechnology
Diagnostics, Pharmaceuticals

1.03B

20.6%

-

-47.6%

-

-29.8%

NANO
Nanobiotix S.A

Biotechnology
Nanoparticle, Radiotherapy

1.00B

41.7%

-

72.3%

-

317%

DAWN
Day One

Biotechnology
Tovorafenib, DAY301, VRK1 Inhibitor

999M

31.3%

-

-73.5%

-

-47.7%

RZLT
Rezolute

Biotechnology
Antibody, Hyperinsulinism

998M

36.3%

-

68.6%

-

54.7%

XNCR
Xencor

Biotechnology
Engineered Monoclonal Antibodies

993M

19.3%

-

-73.3%

-

-48.0%

NBTX
Nanobiotix

Biotechnology
Nanoparticles, Radiotherapy

968M

46.0%

-

74.1%

-

355%

CSTL
Castle Biosciences

Biotechnology
Melanoma, Squamous, Uveal

964M

53.8%

-

11.7%

-

-5.80%

URGN
UroGen Pharma

Biotechnology
Jelmyto, UGN-102, UGN-103

947M

34.6%

-

65.5%

-

72.7%

ANAB
AnaptysBio

Biotechnology
Antibody, Autoimmune

941M

24.6%

-

34.7%

-

40.7%

KOD
Kodiak Sciences

Biotechnology
Anti-VEGF, Biopolymer Conjugate

931M

35.8%

-

42.4%

-

201%

IOVA
Iovance

Biotechnology
Amtagvi, Proleukin, Lifileucel

913M

42.7%

-

-82.9%

-

-76.5%

KURA
Kura Oncology

Biotechnology
Menin Inhibitor, Farnesyl

891M

49.6%

-

-36.6%

-

-47.2%

SPRY
ARS

Biotechnology
Epinephrine, Nasal Spray

875M

28.5%

-

8.02%

-

-47.6%

BHVN
Biohaven

Biotechnology
Troriluzole, Taldefgrobep

874M

41.2%

-

-62.7%

-

-85.5%

ABUS
Arbutus Biopharma

Biotechnology
RNAi Therapeutic, PD-L1 Inhibitor

863M

31.2%

-

48.8%

-

9.68%

PVLA
Palvella

Biotechnology
Topical Rapamycin Gel, Microcystic

861M

25.7%

-

27.1%

-

339%

PROK
ProKidney

Biotechnology
Cell Therapy, Renal Cells

853M

53.4%

-

-30.0%

-

-3.30%

TYRA
Tyra Biosciences

Biotechnology
Precision Medicine Platform, FGFR

844M

32.1%

-

27.1%

-

-13.0%

GHRS
GH Research

Biotechnology
Mebufotenin, Depression

837M

27.1%

-

40.1%

-

30.4%

VIR
Vir Biotechnology

Biotechnology
HDV, RSV, HPV, Coronavirus, TCE

828M

33.0%

-

-83.5%

-

-46.5%

VLA
Valneva SE

Biotechnology
Japanese Encephalitis, Cholera

805M

18.1%

-

-6.42%

-

45.3%

GLUE
Monte Rosa

Biotechnology
MRT-2359, MRT-6160, MRT-8102, CDK2

802M

86.3%

-

20.3%

38.5

45.7%

RAPT
RAPT Therapeutics

Biotechnology
CCR4 Antagonist, Inflammation

800M

29.4%

-

-28.3%

-

99.9%

BCAX
Bicara

Biotechnology
Ficerafusp Alfa, Bifunctional

800M

27.9%

-

-56.1%

-

-43.1%

CDNA
CareDx

Biotechnology
Kidney, Heart, Transplant

798M

50.1%

-

-38.0%

14.3

-38.8%

SVRA
Savara

Biotechnology
Molgramostim, Proteinosis

795M

26.5%

-

68.1%

-

15.1%

DNA
Ginkgo Bioworks

Biotechnology
Cell Engineering, Biosecurity

769M

18.4%

-

-46.6%

-

-18.3%

SION
Sionna

Biotechnology
Galicaftor, Navocaftor, SION-109

769M

34.4%

-

90.0%

-

78.3%

CMPX
Compass

Biotechnology
Tovecimig, CTX-471, CTX-8371

752M

24.6%

-

29.8%

-

148%

AVBP
ArriVent

Biotechnology
Firmonertinib, ARR-217, ARR-002

746M

42.6%

-

-23.1%

-

-45.8%

RIGL
Rigel

Biotechnology
Kinase, Inhibitor

725M

92.6%

-

64.4%

6.45

27.7%

LXEO
Lexeo

Biotechnology
Gene Therapy, Cardiomyopathy

720M

34.7%

-

-20.5%

-

3.31%

LENZ
LENZ Therapeutics

Biotechnology
Presbyopia, Accommodative

719M

38.5%

1.0%

8.82%

-

-36.0%

ORGO
Organogenesis

Biotechnology
Wound Care, Surgical Matrix

715M

33.6%

-

48.1%

-

23.1%

ATXS
Astria Therapeutics

Biotechnology
Monoclonal, Antibody, Plasma

706M

32.0%

-

22.2%

-

2.94%

REPL
Replimune

Biotechnology
Oncolytic Immunotherapy, RP1, RP2

683M

28.0%

-

-74.3%

-

-32.6%

GERN
Geron

Biotechnology
telomerase, inhibitor, oncology

683M

28.8%

-

-65.1%

-

-73.9%

MGTX
MeiraGTx Holdings

Biotechnology
Gene Therapies, Retinal Diseases

681M

27.2%

-

33.2%

-

3.01%

PRME
Prime Medicine

Biotechnology
Gene Editing, Prime Editing

679M

40.5%

-

-43.7%

-

-26.2%

EBS
Emergent

Biotechnology
Vaccine, Antitoxin, Auto-Injector

655M

52.4%

0.14%

-18.6%

9.45

-9.12%

ERAS
Erasca

Biotechnology
Naporafenib, ERAS-0015, ERAS-4001

644M

34.7%

-

-50.5%

-

-21.8%

MLTX
MoonLake

Biotechnology
Nanobody, IL-17A, IL-17F

641M

29.0%

-

13.6%

-

-78.4%

ESPR
Esperion

Biotechnology
Cholesterol-Lowering Tablets

631M

52.3%

-

-34.1%

-

16.5%

AVXL
Anavex Life

Biotechnology
Cns,Alzheimer,Parkinson,Rett,Epilep..

626M

30.1%

-

-51.3%

-

-43.8%

IVA
Inventiva

Biotechnology
Lanifibranor, Odiparcil, TGF-Beta

622M

46.0%

-

13.0%

-

26.1%

BCYC
Bicycle

Biotechnology
Bicycle, Conjugate, Nectin-4

607M

38.9%

-

-85.1%

-

-75.1%

CTMX
CytomX Therapeutics

Biotechnology
Antibody-Drug Conjugate, T-Cell

597M

60.6%

-

50.9%

7.24

236%

MYGN
Myriad Genetics

Biotechnology
Hereditary Cancer, Companion

587M

34.6%

0.08%

-78.9%

-

-64.7%

VSTM
Verastem

Biotechnology
Avutometinib, Defactinib

582M

40.8%

-

44.5%

-

73.7%

FDMT
4D Molecular

Biotechnology
Ophthalmology, Cystic-Fibrosis

578M

28.5%

-

-24.3%

-

17.1%

OLMA
Olema

Biotechnology
Palazestrant, OP-3136, KAT6

573M

33.4%

-

21.5%

-

-39.3%

PRTA
Prothena

Biotechnology
Neurodegeneration, Antibody

568M

26.6%

-

-75.5%

-

-48.1%

CRVS
Corvus

Biotechnology
Kinase Inhibitor, Adenosine

568M

32.0%

-

46.4%

-

-20.8%

RGNX
Regenxbio

Biotechnology
Gene,Therapy,AAV,Platform,Pipeline

567M

23.4%

-

-25.8%

-

-4.23%

IVA
Inventiva S.A

Biotechnology
Lanifibranor, Odiparcil, TGF-Beta

565M

43.3%

-

9.20%

-

16.5%

Stocks & ETFs Screener: 200+ results (Biotechnology)

Basic Filter

Fundamental Filter

Benchmark

Performance/Technical